Mylan Pharmaceuticals Inc v. Sanofi Aventis DeutshLand GmbH

Richard Torczon

Lorelei Westin

Jovial Wong

Jad A. Mills

Arthur P. Dykhuis

Tasha Thomas

W. Karl Renner

Joshua Griswold

Adrian Percer

John S. Goetz

Elizabeth Weiswasser

Matt Colvin

William S. Ansley

Kathryn M. Kantha

Sudip Kundu

Matthew Sieger

Andrew Gesior

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Mylan targets Sanofi's pen injector patent with 3 obviousness challenges, citing Burroughs & Steenfeldt-Jensen against the core drive mechanism claim.

Mylan Pharmaceuticals Inc

Sanofi-Aventis Deutschland GmbH

Last Docket Entry Date

Total Docket Entries

IPR2018-01670 | Mylan Pharmaceuticals Inc v. Sanofi Aventis DeutshLand GmbH | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
Bart A Gerstenblith	500+	60%	77%
Hyun J Jung	600+	69%	87%
James A Tartal	400+	64%	79%
James J Mayberry	400+	61%	84%

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Richard Torczon	L2 A
Arthur P. Dykhuis	L1 C
Lorelei Westin	-- -- --
Jad A. Mills	-- -- --
Tasha Thomas	-- -- --
Winston & Strawn LLP	L5 C
Jovial Wong	L5 A

Name	Ratings
Weil Gotshal & Manges LLP	L5 A
Adrian Percer	L5 A
Elizabeth Weiswasser	L3 E
Matthew Sieger	L1 D
William S. Ansley	-- -- --
Kathryn M. Kantha	-- -- --
Sudip Kundu	-- -- --
Andrew Gesior	-- -- --
Fish & Richardson	L5 A
W. Karl Renner	L5 A
Joshua Griswold	L5 A
John S. Goetz	L5 E
Matt Colvin	-- -- --